Tim Chiang, BTIG Specialty Pharmaceuticals and Biotechnology Analyst, discusses Valeant on CNBC.
BTIG’s Tim Chiang Appears on CNBC to Discuss the Latest Valeant News
BTIG is now part of U.S. Bancorp. Together, we bring complementary capabilities to support institutional and corporate clients. Take a closer look.
Client Login
Home > News & Events > BTIG’s Tim Chiang Appears on CNBC to Discuss the Latest Valeant News